Literature DB >> 7705193

The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy.

M Tawata1, A Kurihara, K Nitta, E Iwase, N Gan, T Onaya.   

Abstract

Goshajinkigan, a herbal medicine, has long been used in Japan to alleviate the subjective symptoms of diabetic neuropathy; however, its effects have not been confirmed objectively. We evaluated its effects on subjective symptoms and on vibration sensation in patients with diabetic neuropathy. The oral administration of 7.5 g/day of Goshajinkigan for 3 months (treatment period) relieved subjective symptoms of numbness in 9 of 13 patients. When the drug was discontinued for 2 months as a washout period, the subjective symptom worsened in 7 of 13 patients. Chi-square analysis revealed significant effects of Goshajiniagan on subjective symptoms (P < 0.001 for numbness and P < 0.05 for cold sensation). Vibration sensation was evaluated by measuring vibratory threshold using an SMV-5 vibrometer. There were significant changes in vibratory thresholds by paired t-test (P < 0.05) both in the upper and the lower extremities during the treatment and washout periods. Chi-square analysis also revealed a significant effect of Goshajinkigan on vibratory threshold (P < 0.01). There was no significant change in glycosylated hemoglobin as a whole during the study. These observations confirm that Goshajinkigan relieves subjective symptoms and demonstrate that it improves vibration sensation in patients with diabetic neuropathy.

Entities:  

Mesh:

Year:  1994        PMID: 7705193     DOI: 10.1016/0168-8227(94)90149-x

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  29 in total

1.  Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.

Authors:  Eiji Oki; Yasunori Emi; Hiroshi Kojima; Jun Higashijima; Takeshi Kato; Yasuhiro Miyake; Masanori Kon; Yutaka Ogata; Kenichi Takahashi; Hideyuki Ishida; Hiroshi Saeki; Yoshihisa Sakaguchi; Takeharu Yamanaka; Toru Kono; Naohiro Tomita; Hideo Baba; Ken Shirabe; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2015-01-28       Impact factor: 3.402

2.  Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.

Authors:  Nobuaki Hoshino; Riki Ganeko; Koya Hida; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2017-12-21       Impact factor: 3.402

3.  Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.

Authors:  Akira Kuriyama; Koji Endo
Journal:  Support Care Cancer       Date:  2017-12-26       Impact factor: 3.603

4.  Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

Authors:  Claudia Wing; Masaaki Komatsu; Shannon M Delaney; Matthew Krause; Heather E Wheeler; M Eileen Dolan
Journal:  Stem Cell Res       Date:  2017-06-15       Impact factor: 2.020

5.  Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.

Authors:  Nobuaki Hoshino; Koya Hida; Riki Ganeko; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2016-11-26       Impact factor: 2.571

6.  The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice.

Authors:  Keisuke Shibata; Takeshi Sugawara; Kayoko Fujishita; Youichi Shinozaki; Takashi Matsukawa; Tsutomu Suzuki; Schuichi Koizumi
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

7.  Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling.

Authors:  Bolin Qin; Masaru Nagasaki; Ming Ren; Gustavo Bajotto; Yoshiharu Oshida; Yuzo Sato
Journal:  Evid Based Complement Alternat Med       Date:  2004-07-21       Impact factor: 2.629

8.  Analgesic Effect of Combined Therapy with the Japanese Herbal Medicine "Yokukansan" and Electroacupuncture in Rats with Acute Inflammatory Pain.

Authors:  Nachi Ebihara; Hideshi Ikemoto; Naoki Adachi; Takayuki Okumo; Taro Kimura; Kanako Yusa; Satoshi Hattori; Atsufumi Manabe; Tadashi Hisamitsu; Masataka Sunagawa
Journal:  Medicines (Basel)       Date:  2021-06-17

9.  Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

Authors:  Toru Kono; Noriaki Mamiya; Naoyuki Chisato; Yosiaki Ebisawa; Hirotaka Yamazaki; Jiro Watari; Yasuhiro Yamamoto; Shigetaka Suzuki; Toshiyuki Asama; Kazunori Kamiya
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-11       Impact factor: 2.629

10.  Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?

Authors:  Sven Schröder; Kathrin Beckmann; Giovanna Franconi; Gesa Meyer-Hamme; Thomas Friedemann; Henry Johannes Greten; Matthias Rostock; Thomas Efferth
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.